Combination HIV pill might be available in 2006

01/11/2006 | Los Angeles Times (tiered subscription model)

Gilead CEO John Martin says the triple combination HIV pill, to be sold with Bristol-Myers Squibb and Merck, may be on the market this year. Martin says his company will file with the FDA during the second quarter for approval of the drug, the first to combine three HIV medicines in a once-a-day pill.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY